Fibrocell science, inc. (FCSC)
CashFlow / Yearly
Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10
Cash flows from operating activities:
Net Income (Loss) Attributable to Parent

-10,300

-16,240

-15,292

-34,453

-25,650

-31,554

-12,687

-24,025

-12,879

Adjustments to reconcile net income (loss) to net cash used in operating activities:
Reorganization items, net

-

-

-

-

-

-

-

-

0

Loss on extinguishment of debt

-

-

-

-

-

-

-5,617

-

-

Gain on sale of Agera

-

-

-

-

-

-

467

-

-

Stock issued to related party for exclusive channel collaboration agreement

-

-

-

-

5,154

6,406

6,917

-

-

Stock-based compensation expense

526

322

1,933

2,038

1,239

1,150

1,224

2,900

-992

Warrant liability revaluation income

921

4,920

11,884

2,929

3,930

-1,053

-

-

-

Warrant revaluation and other finance (income) expense

-

-

-

-

-

-

20,404

2,562

-465

Unrealized Gain (Loss) on Derivatives

1,700

-1,407

-462

0

-

-

-23

-5,452

0

Deferred tax benefit

-

-

-

-

0

0

2,500

-

-

Loss on disposal or impairment of property and equipment

0

-40

-69

-56

-13

-5

0

-

-

Uncompensated contribution of services

-

-

-

-

-

-

-

-

0

Depreciation and amortization of long lived assets

392

384

564

767

883

863

821

158

8

Amortization of discount on convertible debt converted to common shares

0

86

0

-

-

-

-

-

-

Intangible asset impairment

-

-

3,905

0

-

-

-

-

-

Recovery of doubtful accounts

-

-

-12

-5

12

-20

-

-

-

Loss on write-down of inventory

-

-

356

0

-

-

-

-46

60

Provision for doubtful accounts

-

-

-

-

-

-

-

18

-7

Provision for doubtful accounts

-

-

-

-

-

-

25

-

-

Amortization of debt issuance costs

-

-

-

-

-

-

146

-

0

Decrease (increase) in operating assets:
Amortization of debt discounts on investments

-

-

-

-

-

-

-

-

0

Loss on disposal or impairment of property and equipment

-

-

-

-

-

-

-

-

0

Foreign exchange gain on substantial liquidation of foreign entity

-

-

-

-

-

-

-

-

5

Accounts receivable

-

-

-12

-9

-12

-54

60

4

-47

Other receivables

-

-

-

-

-

-

-

1

4

Inventory

-

-

-126

-89

-26

120

477

-38

-27

Prepaid expenses and other current assets

-380

-28

-796

-35

-

-

-

-

-

Prepaid expenses and other current assets

-

-

-

-

76

-69

196

437

-42

Other assets

-38

-26

65

0

-214

215

0

-

0

Increase (decrease) in operating liabilities:
Accounts payable

-24

69

-139

-114

-1,065

807

-966

803

851

Related party payable

-2,203

1,361

-9,778

9,719

-290

1,230

-

-

-

Accrued expenses, deferred rent

263

-342

-214

641

894

188

407

816

-

Accrued interest payable

771

742

228

0

-

-

-

-

-

Increase in accrued expenses and other

-

-

-

-

-

-

-

-

1,256

Deferred revenue

-

-

-457

41

268

9

83

55

0

Miscellaneous other

-

-

-

-

-

-

-81

-2

-

Net Cash Provided by (Used in) Operating Activities

-12,700

-17,037

-29,390

-24,106

-22,296

-20,075

-22,575

-16,837

-9,265

Cash flows from investing activities:
Acquisition of Agera, net of cash acquired

-

-

-

-

-

-

-

-

0

Purchase of property and equipment

164

433

253

271

242

360

493

1,570

29

Proceeds from the sale of property and equipment

-

-

1

26

0

0

-

-

0

Proceeds from the sale of Agera

-

-

-

-

-

-

1,002

-

-

Purchase of investments

-

-

-

-

-

-

-

-

0

Proceeds from sales and maturities of investments

-

-

-

-

-

-

-

-

0

Net cash used in investing activities

-164

-433

-252

-245

-242

-360

509

-1,570

-29

Cash flows from financing activities:
Payment of deferred offering costs

444

0

42

0

-

-

-

-

-

Proceeds from private placement

900

7,623

17,933

0

-

-

-

-

0

Debt issuance costs

-

-

-

-

-

-

46

100

0

Offering costs associated with the issuance of convertible debt

-

-

-

-

-

-

-

-

0

Net proceeds from preferred stock

-

-

-

-

-

-

7,864

5,836

-

Proceeds from notes payable to shareholders, net

-

-

-

-

-

-

-

-

0

Proceeds from conversion of pre-funded warrants

-

-

-

-

-

-

-

2,419

0

Proceeds from Registered Direct Offering, net of offering costs

8,915

9,749

0

15,872

0

47,118

40,185

22,168

3,469

Proceeds from exercise of common warrants

499

0

-

-

-

-

-

-

-

Proceeds from conversion of pre-funded warrants

24

0

-

-

-

-

-

-

-

Proceeds from the exercise of stock options

-

-

-

255

0

0

-

-

-

Subscription received

-

-

-

-

0

2,004

0

-

-

Principal payments on capital lease obligations

-

-

2

3

0

0

-

-

-

Costs associated with secured loan and debtor-in-possession loan

-

-

-

-

-

-

-

-

0

Proceeds from secured loan

-

-

-

-

-

-

-

-

0

Proceeds from debtor-in-possession loan

-

-

-

-

-

-

-

-

0

Payments on insurance loan

-

-

-

-

-

-

97

81

63

Principal payments on note payable

-

-

-

-

-

-

4,823

1,283

0

Dividends paid on preferred stock

-

-

-

-

-

-

470

623

139

Cash paid for fractional shares of preferred stock

-

-

-

-

-

-

-

-

0

Merger and acquisition expenses

-

-

-

-

-

-

-

-

0

Repurchase of common stock

-

-

-

-

-

-

-

-

0

Net cash provided by (used in) financing activities

9,894

17,372

17,889

16,124

0

49,122

42,613

28,336

8,794

Effect of exchange rate changes on cash balances

-

-

-

-

-

-

-

3

5

Net decrease in cash and cash equivalents

-2,987

-98

-11,753

-8,227

-22,538

28,687

20,547

9,931

-494

Supplemental disclosures of cash flow information:
Property and equipment in accounts payable

9

29

57

11

0

0

-

-

-

Offering costs in accounts payable and accrued expenses

37

444

23

0

-

-

-

-

-

Reduction of warrant liability upon cashless exercise of warrants

0

41

0

82

0

352

-

-

-

Reduction of accrued interest payable upon cashless exercise of promissory notes

0

3

0

-

-

-

-

-

-

Reduction in derivative liability upon cashless exercise of promissory notes

0

6

0

-

-

-

-

-

-

Cashless exercise of promissory notes

0

85

0

-

-

-

-

-

-

Dividend paid in-kind to preferred stockholders

336

264

0

-

-

-

-

-

-

Preferred Stock, Deemed Dividend

513

4,099

0

-

-

-

-

-

-

Cash paid for interest

-

-

-

-

-

-

-

-

0

Predecessor deemed dividend associated with beneficial conversion of preferred stock

-

-

-

-

-

-

-

-

0

Predecessor preferred stock dividend

-

-

-

-

-

-

-

-

0

Successor accrued preferred stock dividend

-

-

-

-

-

-

-

-

191

Predecessor uncompensated contribution of services

-

-

-

-

-

-

-

-

0

Predecessor common stock issued for intangible assets

-

-

-

-

-

-

-

-

0

Predecessor common stock issued in connection with conversion of debt

-

-

-

-

-

-

-

-

0

Predecessor equipment acquired through capital lease

-

-

-

-

-

-

-

-

0

Successor/Predecessor financing of insurance premiums

-

-

-

-

-

-

-

-

97

Successor issuance of notes payable

-

-

-

-

-

-

-

-

0

Successor common stock issued in connection with reorganization

-

-

-

-

-

-

-

-

0

Successor intangible assets

-

-

-

-

-

-

-

-

0

Successor deferred tax liability in connection with fresh-start

-

-

-

-

-

-

-

-

0

Elimination of Predecessor common stock and fresh-start adjustment

-

-

-

-

-

-

-

-

0

Successor subscription receivable

-

-

-

-

-

-

-

-

210

Successor accrued warrant liability

-

-

-

-

-

-

-

-

7,071

Successor conversion of preferred stock derivative balance into common stock

-

-

-

-

-

-

-

-

0

Successor cashless exercise of warrants recorded previously as a liability

-

-

-

-

-

-

-

-

0

Successor accrued derivative liability

-

-

-

-

-

-

-

-

2,120